PleuraFlow chest tube clearance system cleared by FDA
This article was originally published in Clinica
The US FDA has granted 510(k) clearance for the PleuraFlow active tube clearance system developed by Clear Catheter Systems. It is designed to clear chest tubes in patients who have undergone heart and/or lung surgery. These tubes are inserted into the chest to remove air or fluid – if they become clogged blood can build up around the heart and lungs, leading to complications and sometimes death. PleuraFlow uses a specially-designed clearance member that breaks down clots and pulls them out of the tube. Bend, Oregon-based Clear Catheter Systems CE marked the device for sale in Europe in June, and it is also approved in Canada. The firm estimates that the worldwide market for the system is $5bn.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.